SeqLL (SQLLW) Stock Analysis

What SeqLL does

SeqLL Inc. operates globally as a life science instrumentation and specialized research services firm. Its core objective is to pioneer the development of scientific assets and proprietary intellectual property across various "omics" disciplines. Central to SeqLL's offerings is its innovative True Single Molecule Sequencing (tSMS) platform. This advanced technology provides a direct single-molecule solution for both DNA and RNA sequencing by precisely detecting individual nucleic acids. It enables researchers to analyze billions of distinct molecules in a single experimental run, thereby generating highly accurate and reproducible data. The company's solutions address a range of applications, including biomarker discovery and the creation of diagnostic assays. Its clientele is diverse, encompassing academic institutions, dedicated scientific research centers, government agencies, and companies in the biotechnology and pharmaceutical sectors. SeqLL is actively involved in numerous collaborations to further its technology and explore new applications. These include a research and development partnership with the U.S. Department of Justice's Federal Bureau of Investigation (FBI) to evaluate the forensic capabilities of direct RNA sequencing using the tSMS platform. Another significant alliance is with True Bearing Diagnostics, Inc., where tSMS is being employed to analyze whole-blood RNA to identify transcripts associated with coronary artery disease. Further collaborations extend to: The Bernstein Laboratory, focusing on fundamental questions in chromatin biology and epigenetic regulation; The Ting Laboratory; The Jackson Laboratory for Genomic Medicine, where SeqLL assists in developing novel methods for single-molecule resolution chromatin interaction analysis in individual nuclei; the Weizmann Institute of Science, recognized for its development and application of innovative single-molecule technologies; and Tetracore, Inc., to whom SeqLL supplies tSMS systems and provides on-site support. Founded in 2013, SeqLL Inc. is headquartered in Billerica, Massachusetts.

Key metrics

ETFs linked to SQLLW

Broad-market and Healthcare sector ETFs an investor holding SeqLL is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SQLLW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for SeqLL?

SeqLL trades under the ticker SQLLW on NASDAQ.

Which exchange is SQLLW listed on?

SQLLW is listed on NASDAQ.

What sector does SeqLL operate in?

SeqLL is classified in the Healthcare sector (Medical - Diagnostics & Research industry).

How can PortView help analyze SQLLW in a portfolio?

PortView shows SQLLW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.